Evidence-informed educational review. Updated 10 November 2026. Follow current local product labeling and individualized clinical guidance.
An acute cough from a respiratory infection often improves within three to four weeks. Before recommending a cough medicine, ask how long the cough has lasted, whether it brings up substantial sputum and whether the person is breathless or systemically unwell. Rapid deterioration or signs of pneumonia need clinical evaluation. A suppressant can reduce a symptom while leaving its cause untreated. [1]
Pediatric safety
The FDA advises against OTC cough/cold medicines in children younger than two due to potentially life-threatening effects, and manufacturers commonly label products ‘do not use under four years’. For older children, follow age-specific labeling and avoid duplicate ingredients across combination products. Codeine/hydrocodone prescription cough products have important age-based restrictions and should not be used routinely in children. Honey may provide modest cough relief for children over one year; never give honey to infants younger than 12 months [2, 3].
A dry cough and a productive cough have different goals
Dextromethorphan acts centrally to reduce the cough reflex. Guaifenesin is an expectorant intended to loosen mucus and make secretions easier to clear. Neither is essential for an uncomplicated viral cough. NICE describes limited evidence of benefit from guaifenesin or a non-codeine suppressant in people aged 12 years and older. Excessive secretions or a persistent cough, such as one associated with asthma, makes self-treatment with a suppressant inappropriate. [1, 4]
Check all active ingredients in combination products before adding another preparation. Two bottles with different brand names can contain the same suppressant. Dextromethorphan-containing products should be avoided during treatment with a monoamine oxidase inhibitor and for 14 days after stopping it. Ask about prescription medicines before use. [4]
Benzonatate and opioid cough medicines
Benzonatate acts peripherally by reducing activity of stretch receptors in the respiratory tract. Swallow the capsule whole. Chewing it can anaesthetise the mouth and throat, impair swallowing and cause choking. Accidental ingestion by a young child can produce seizures or cardiovascular collapse within minutes and has caused deaths. Suspected accidental ingestion requires immediate emergency help. [5]
Codeine and hydrocodone can depress respiration and cause sedation, dependence and overdose. US prescription cough and cold products containing these opioids are limited to adults aged 18 years and older. Alcohol and other central nervous system depressants increase risk. NICE found little evidence that codeine relieves acute cough. These risks and the modest expected benefit weigh against routine use for a viral respiratory infection. [6, 1]
When the cough persists
Reassess a cough that worsens or fails to improve over the expected course. Fever with worsening breathlessness, systemic illness or an underlying condition that increases complication risk changes the assessment. For an uncomplicated acute cough linked to an upper respiratory infection or acute bronchitis, NICE advises against offering mucolytics such as acetylcysteine or carbocisteine. Disease-specific treatment of chronic mucus retention is a separate clinical decision. [1]
References
- National Institute for Health and Care Excellence. Cough (acute): antimicrobial prescribing. NG120. 2019. [cited 2026 Nov 10]. View source.
- US Food and Drug Administration. Should you give kids medicine for coughs and colds? Consumer update. 2025. Available from: https://www.fda.gov/consumers/consumer-updates/should-you-give-kids-medicine-coughs-and-colds
- US Food and Drug Administration. Use caution when giving cough and cold products to kids. 2026. Available from: https://www.fda.gov/drugs/safe-use-over-counter-otc-medicines-children/use-caution-when-giving-cough-and-cold-products-kids
- National Library of Medicine. Mucus Relief DM (dextromethorphan and guaifenesin). DailyMed drug label. [cited 2026 Nov 10]. View source.
- National Library of Medicine. Benzonatate capsules, USP. DailyMed prescribing information. [cited 2026 Nov 10]. View source.
- US Food and Drug Administration. Labelling changes for prescription opioid cough and cold medicines to limit use to adults aged 18 years and older. 2018. [cited 2026 Nov 10]. View source.
Medical & AI Disclaimer
The information provided on Sumathi Publications is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional regarding any medical condition or treatment decision.
We strive to keep our content accurate and up to date; however, some content may be created or assisted using artificial intelligence (AI) and may contain errors or omissions. All information should be independently verified before use. Reliance on any content provided by Pharmacology Mentor is at your own risk.